UNICA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.
EnglishThe serine/threonine protein kinase glycogen synthase kinase-3 (GSK-3) has recently been identified as one of the key targets of mood stabilizing agents and antipsychotic drugs. These drugs have been found to promote the phosphorylation at serine 9 (Ser9) and the consequent inactivation of GSK-3β, thereby inhibiting GSK-dependent intracellular signaling. We have previously shown that N-desmethylclozapine (NDMC), a major metabolite of the atypical antipsychotic clozapine, is a potent and efficacious ð opioid receptor agonist. In the present study, we investigated whether NDMC regulates GSK-3β phosphorylation by acting at δ opioid receptor (DOR). We found that in Chinese hamster ovary cells transfected whith the human DOR and in NG108-15 neuroblastoma x glioma hybrid cells expressing endogenous DOR NDMC induced a rapid phosphorylation of GSK-3β at Ser9. This effect was mimicked by the δ opioid receptor ogonist DPDPE and was blocked by naloxone. In addition, in both cell systems NDMC and DPDPE induced the phosphorylation of the protein kinase Akt-1. Pretreatment of cells with the phosphatidylinositol 3 kinase (PI3K) inhibitor worthmannin markedly reduced the stimulatory effect of NDMC on GSK-3β and Akt-1 phosphorylation. These data indicate that NDMC can regulate GSK-dependent signaling by stimulating δ opioid receptors coupled to the PI3K/AKt pathway and suggest that this property may contribute to the antidepressant and atypical antipsychotic activity of clozapine.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | N-desmethylclozapine, a major clozapine metabolite, regulates glycogen synthase 3-β through stimulation of ð opioid receptors and PI3 kìnase/AKt pathway. |
| Autori: | |
| Data di pubblicazione: | 2007 |
| Abstract: | The serine/threonine protein kinase glycogen synthase kinase-3 (GSK-3) has recently been identified as one of the key targets of mood stabilizing agents and antipsychotic drugs. These drugs have been found to promote the phosphorylation at serine 9 (Ser9) and the consequent inactivation of GSK-3β, thereby inhibiting GSK-dependent intracellular signaling. We have previously shown that N-desmethylclozapine (NDMC), a major metabolite of the atypical antipsychotic clozapine, is a potent and efficacious ð opioid receptor agonist. In the present study, we investigated whether NDMC regulates GSK-3β phosphorylation by acting at δ opioid receptor (DOR). We found that in Chinese hamster ovary cells transfected whith the human DOR and in NG108-15 neuroblastoma x glioma hybrid cells expressing endogenous DOR NDMC induced a rapid phosphorylation of GSK-3β at Ser9. This effect was mimicked by the δ opioid receptor ogonist DPDPE and was blocked by naloxone. In addition, in both cell systems NDMC and DPDPE induced the phosphorylation of the protein kinase Akt-1. Pretreatment of cells with the phosphatidylinositol 3 kinase (PI3K) inhibitor worthmannin markedly reduced the stimulatory effect of NDMC on GSK-3β and Akt-1 phosphorylation. These data indicate that NDMC can regulate GSK-dependent signaling by stimulating δ opioid receptors coupled to the PI3K/AKt pathway and suggest that this property may contribute to the antidepressant and atypical antipsychotic activity of clozapine. |
| Handle: | http://hdl.handle.net/11584/90725 |
| Tipologia: | 4.3 Poster |
File in questo prodotto:
Copyright © 2021